In this post on the Center for Global Development’s (CGD) “Global Health Policy” blog, Denizhan Duran and Amanda Glassman of CGD review the proposed FY12 federal global health appropriation approved recently by Congress. They state that “this year’s budget is a missed opportunity in a period defined by budget pressures: global…
Recounting the factors that led to and conditions that persisted during the North Korean famine between 1995 and 1998, New Yorker staff writer Steve Coll says in this opinion piece in the magazine, “Better harvests and international food aid ended the worst suffering by 1998. Yet chronic food insecurity and shortages persist to this day.”
Across Africa, “lesbian, gay, bisexual and transgender people suffer brutal attacks, yet cannot report them to the police for fear of additional violence, humiliation, rape or imprisonment at the hands of the authorities. We are expelled from school and denied health care because of our perceived sexual orientation or gender identity,” Frank Mugisha, 2011 Robert F. Kennedy Human Rights Award laureate and executive director of Sexual Minorities Uganda, writes in a New York Times opinion piece. He adds, “When Secretary of State Hillary Rodham Clinton announced this month that the United States would use diplomacy to encourage respect for gay rights around the world, my heart leapt.”
The U.S. Food and Drug Administration’s approval of the tuberculosis (TB) drug Sirturo, also known as bedaquiline, “appears to be just the first step in an exciting renaissance for TB drug development,” Mark Harrington, executive director of Treatment Action Group (TAG), writes in the Bill & Melinda Gates Foundation’s “Impatient Optimists” blog. “Another new drug, delamanid, is currently in late clinical trials and has been submitted to the European Medicines Agency for review as a treatment for [multidrug-resistant (MDR)] TB,” he notes. Harrington concludes, “It’s an exciting time for TB treatment, but much more needs to be done and more resources are needed. We need to focus not only on the discovery and development of new drugs, but also on ensuring that news drugs are delivered to those who need them and in combinations that can prevent the emergence of new types of drug resistance” (12/28).
“Thanks to a herculean effort by health advocates, 78 percent of children in low-income countries receive the basic set of childhood vaccines, covering diphtheria, tetanus, pertussis, hepatitis B and haemophilus influenza,” a Bloomberg View editorial states. However, “[t]his campaign will be disrupted, and lives lost, if immunization critics win their latest battle for an international ban on a vaccine component” — thimerosal, a mercury-containing organic compound — “that has proved to be safe time and time again,” the editorial writes, noting, “Groups such as the Coalition for Mercury-Free Drugs and the Coalition for SafeMinds are pressing their case before the United Nations Environmental Program [UNEP] meets on Jan. 13 to prepare a global treaty reducing mercury use.”
Several newspapers published opinion pieces regarding the recent murders of polio vaccination workers in Pakistan. The following summarizes two opinion pieces and one editorial on the issue.
Jose “Oying” Rimon, deputy director of the Bill & Melinda Gates Institute for Population and Reproductive Health at the Johns Hopkins University Bloomberg School of Public Health, and Ben de Leon, president of the Forum for Family Planning and Development, Inc., write in the Bill & Melinda Gates Foundation’s “Impatient Optimists” blog that the many people who worked for 14 years to pass a reproductive health bill in the Philippines are “profiles in courage.” They continue, “This is the story of these courageous people but it’s also a story of resolution in staying the course, abiding with scientific evidence and facts, and the nobility of staying positive against on onslaught of insults and misinformation.” The bill represents “an unparalleled educational process in which common sense and science prevailed,” they conclude (1/2).
“Millions of lives are saved today in developing countries because of bold, innovative financing arrangements over last 10 years. These financing mechanisms are good examples of private sector partnership with public sector for common good,” Taufiqur Rahman, an international health consultant, writes in The Hill’s “Congress Blog.” He describes several examples, including the GAVI Alliance, the Global Fund to Fight AIDS, Tuberculosis and Malaria, the International Finance Facility for Immunization (IFFIm), UNITAID, Clinton Foundation efforts, and the patent pools, Medicines Patent Pool (MPP) and Pool for Open Innovation. Rahman concludes, “Our efforts must be to support and expand these innovative financing mechanisms and promote innovation for efficient pricing arrangements. At the same time, we must ensure that these financing mechanisms remain lean, efficient, and transparent” (1/4).
The Global Network for Neglected Tropical Diseases’ (NTDs) “End the Neglect” blog features two posts discussing the first anniversary of the London Declaration and two recently released reports on progress against NTDs. Simon Bush: Discussing the new NTD Scorecard (.xls) and the “From Promises to Progress” report from Uniting to Combat NTDs,…
“The amount of good our nation has done for poor and hungry people around the world over the last 10 years is astounding,” Rev. David Beckmann, president of Bread for the World; George Ingram, a senior fellow at the Brookings Institution; and former Rep. Jim Kolbe (R-Ariz.), a senior fellow…